|
0
Votes
vote
Bacteria can directly cause human blood and plasma to clotBacteria can directly cause human blood and plasma to clot - a process that was previously thought to have been lost during the course of vertebrate evolution, according to new research at the University of Chicago, National Institute of Allergy and Infectious Diseases, and Institut Pasteur in Pa... |
|
0
Votes
vote
Trius Therapeutics awarded $28 million to develop novel drugs targeting bacterial DNA Gyrase and Topoisomerase IVTrius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathog... |
|
0
Votes
vote
HIV Proven To Be Older Than John McCain (And His Bad AIDS Policies) [Proof Positive]Scientists researching the origins of the Human Immunodeficiency Virus now estimate that it made the jump from chimps to humans in Cameroon decades earlier that initially thought — sometime between 1884 and 1924. They date the virus to that time period based on viral samples discovered from... |
|
0
Votes
vote
SRI International Begins NIAID-Funded Drug Evaluation Program for TuberculosisMENLO PARK, CA--(Marketwire - September 15, 2008) - SRI International, an independent nonprofit research and development organization, today announced the initiation of a tuberculosis (TB) preclinical drug evaluation program in partnership with the National Institute of Allergy and Infectious Di... |
|
0
Votes
vote
National Institute of Allergy and Infectious Diseases Awards Cleveland BioLabs Grant for Protectan CBLB502 Research in Mitigation of Radiation DamageSupports Investigation of Ability to Reduce Occurrence and Severity of Thrombocytopenia and Improve Recovery Time ... |
|
0
Votes
vote
Infectious Disease Research Institute receives $6.3 million NIAID grant to study TB vaccineSeattle's Infectious Disease Research Institute on Tuesday announced it has received a $6.3 million grant from NIH's National Institute of Allergy and Infectious Diseases to study a new tuberculosis vaccine, the Puget Sound Business Journal reports (Puget Sound Business Journal, 8/27). ... |
